Earum Pharmaceuticals Ltd - 542724 - Reg. 34 (1) Annual Report
As per Regulation 34 (1) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 (the Listing Regulations), please find the enclosed Annual Report for your reference and record. Earum Pharmaceuticals Ltd - 542724 - Fixes Book Closure for AGM
Earum Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from December 23, 2020 to December 30, 2020 (both days inclusive) for the purpose of 8th Annual General Meeting (AGM) of the Company to be held on December 30, 2020. Earum Pharmaceuticals Ltd - 542724 - Outcome Of Board Meeting Held On 04/12/2020
1.To convene 8th Annual General Meeting of the Company on Wednesday, the 30th day of December, 2020 at 03:00 P.M. at the Corporate Office of the Company at A-1106, Empire Business Hub, Near AUDA Water Tank, Science City Road, Sola, Ahmedabad, Gujarat -380060, to transact the business specified in the Notice of the AGM. 2.The Company has fixed record date of 22/12/2020 for determining the entitlement of shareholders to get Annual Report and to close the Register of Members & Share Transfer Books of the Company from Wednesday, the 23th December, 2020 to Wednesday, the 30th December, 2020 (both days inclusive) for the purpose of Annual General Meeting of the Company. 3.The Board has approved Notice of Annual General Meeting and Directors Report to be attached in the Annual Report. 4.The Board has adopted the Annual Report for the purpose of Adoption by the shareholders in the Annual General Meeting. 5.The board has Appointment of Scrutinizer for voting at the ensuing 8th AGM of the Com. Earum Pharmaceuticals Ltd - 542724 - Outcome Of Board Meeting Held On 04/12/2020
1. To convene 8th Annual General Meeting of the Company on Wednesday, the 30th day of December, 2020 at 03:00 P.M. at the Corporate Office of the Company, to transact the business specified in the Notice of the AGM. 2. The Company has fixed record date of 22/12/2020 for determining the entitlement of shareholders to get Annual Report and to close the Register of Members & Share Transfer Books of the Company from Wednesday, the 23th December, 2020 to Wednesday, the 30th December, 2020 (both days inclusive) for the purpose of Annual General Meeting of the Company. 3. The Board has approved Notice of Annual General Meeting and Directors Report to be attached in the Annual Report. 4. The Board has adopted the Annual Report for the purpose of Adoption by the shareholders in the Annual General Meeting. 5. The board has Appointment of Scrutinizer for voting at the ensuing 8th AGM of the Company Earum Pharmaceuticals Ltd - 542724 - Shareholding for the Period Ended September 30, 2020
Earum Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here Earum Pharmaceuticals Ltd - 542724 - Compliance Certificate Under Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 30Th September, 2020
Pursuant to requirement of Regulation 7(3) of the Securities and exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby certify that all activities in relation to both physical and electronic share transfer facility are maintained during the period Commencing from 01st April 2020 to 30th September 2020 (both days inclusive) by our Share Transfer Agent viz. Bigshare Services Private Limited having Registration Number is INR000001385. Kindly take note of the above. Earum Pharmaceuticals Ltd - 542724 - Compliance Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 30Th September, 2020
Dear Sir / Madam, Pursuant to Regulation 40(10) of the Securities and exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a certificate Issued by PRO & Co., Company Secretaries for the half year ended on 30th September, 2020 in Compliance with Regulation 40(9) of the above mentioned Regulations. This is for your information and record. Earum Pharmaceuticals Ltd - 542724 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to the requirement of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we hereby enclose the certificate received from our Share Transfer Agent viz. Bigshare Services Private Limited for the quarter ended on 30th September, 2020. This is for your information and record. Earum Pharmaceuticals Ltd - 542724 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- RONAK NARENDRA LALWANIDesignation :- Company Secretary and Compliance Officer Earum Pharmaceuticals Ltd - 542724 - Outcome Of Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended 30.09.2020
With reference to the captioned subject and pursuant to the Regulation 33 of SEBI (LODR) Regulation, 2015, the Board of Directors of the Company at its meeting held on today i.e. Wednesday, 11th November, 2020, inter alia, Considered and approved the unaudited Financial Result, at their respective meeting held today i.e. November 11, 2020 along with Limited Review Report for the quarter and half year ended on 30th September, 2020. Further please find enclosed herewith the unaudited quarterly and half yearly financial result as on 30.09.2020 along with the limited review report taken on record by the Board of Directors. Kindly take the same on record.